UnknownNot applicableNCT00889018

Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma

Studying Retinoblastoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: All India Institute of Medical Sciences
Principal Investigator: Rachna Meel, MS Ophthal
Dr RPC, AIIMS
Intervention: carboplatin(drug)
Enrollment: 60 target
Eligibility: All sexes
Timeline: 2009 – 2012

Study locations (1)

Dr RPC AIIMS, Delhi, National Capital Territory of Delhi, India

Collaborators

Council of Scientific and Industrial Research, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00889018 on ClinicalTrials.gov

Other trials for Retinoblastoma

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT03662776
Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
Memorial Sloan Kettering Cancer Center

See all trials for Retinoblastoma →

← Back to all trials